FDA Person
FDADina A. Tallman
View detailed information about Dina A. Tallman, including compliance records, violations, and related data.
Person Profile
FDA investigator. Took part in 54 inspections of 52 companies, 2023–2026.
Inspections (54)
| Date | Company | Classification | Project area | Inspection |
|---|---|---|---|---|
| August 13, 2026 | Rashmi Chugh, M.D. | Not classified | #1335204 | |
| August 7, 2026 | Organ Recovery Systems, Inc. | Not classified | Project Evaluation: Devices | #1329854 |
| July 17, 2026 | Alexander Glaros, M.D. | Not classified | Bioresearch Monitoring | #1326688 |
| June 26, 2026 | Andreas Hahn, M.D. | Not classified | #1325618 | |
| June 19, 2026 | Maria del Mar Garcia Romero, M.D. | Not classified | Bioresearch Monitoring | #1322714 |
| May 20, 2026 | University Of Michigan - IRBMED | Not classified | Project Evaluation: Devices | #1317988 |
| May 1, 2026 | Khaldoon Alaswad, MD | Not classified | #1316194 | |
| April 15, 2026 | Kristen M. Pettit, M.D. | Not classified | Bioresearch Monitoring | #1312500 |
| March 20, 2026 | Nicolas J. Mouawad, MD | Not classified | Product Evaluation: Medical Devices | #1308284 |
| March 5, 2026 | Aaron L. Ellenbogen, D.O. | VAI | Bioresearch Monitoring | #1306972 |
| February 13, 2026 | Suresh Anne, M.D. | Not classified | Bioresearch Monitoring: Human Drugs | #1302630 |
| January 16, 2026 | Rubi Khaw Li, MD | Not classified | #1298584 | |
| January 9, 2026 | Maria Luisa Tiambeng | NAI | Bioresearch Monitoring | #1300806 |
| November 6, 2025 | Allen L. Hunt, M.D. | Not classified | #1291568 | |
| October 10, 2025 | Vascular Solutions, Inc. | Not classified | Product Evaluation: Medical Devices | #1286616 |
| September 19, 2025 | Corey G. Anderson, M.D. | VAI | Bioresearch Monitoring: Human Drugs | #1282404 |
| August 22, 2025 | Human Subjects Research Committee | Not classified | Bioresearch Monitoring: Human Drugs | #1279190 |
| August 1, 2025 | Mohammad A. Alqarqaz, M.D. | NAI | Bioresearch Monitoring | #1277740 |
| July 16, 2025 | St Joseph Mercy Oakland Instiutional Review Board | NAI | Bioresearch Monitoring | #1276122 |
| June 5, 2025 | Lee G. Wilke, M.D. | Not classified | #1274321 |
Documents (26)
- EIR · CHARLES RIVER LABORATORIES · July 16, 2021
- 483 · Dawes Fretzin Clinical Research Group, Llc. · May 1, 2025
- 483 · Labcorp Clinical Research Unit, Inc. · October 7, 2022
- 483 · Northern Biomedical Research, Inc. · March 29, 2024
- 483 · Moshe Talpaz, MD · June 17, 2021
- 483 · Vascular Solutions, Inc. · October 10, 2025
- 483 · Randy D. Hicks, M.D. · September 12, 2024
- 483 · Rowena Punzalan, M.D. · February 7, 2025
- 483 · Scott A. Fretzin, M.D. · May 1, 2025
- 483 · Human Subjects Research Committee · August 22, 2025
- 483 · Blair M. Brengle, M.D. · July 8, 2021
- 483 · Corey G. Anderson, M.D. · September 19, 2025
- 483 · Francis P. Worden, M.D. · April 4, 2023
- 483 · Robert M. Pascuzzi, M.D. · January 27, 2023
- 483 · University Of Michigan - IRBMED · September 2, 2022
- EIR · Donna S. Hrozencik, M.D. · January 26, 2022
- 483 · Labcorp Early Development Laboratories, Inc. · August 30, 2023
- 483 · Eli Lilly & Company · September 15, 2023
- 483 · Steven W. Pipe, M.D. · October 24, 2022
- 483 · Suresh Anne, M.D. · May 19, 2023
- 483 · Labcorp Early Development Laboratories, Inc. · July 12, 2024
- 483 · Donna S. Hrozencik, M.D. · January 26, 2022
- 483 · Suresh Anne, M.D. · February 13, 2026
- 483 · Kristen M. Pettit, M.D. · April 15, 2026
- 483 · Nicolas J. Mouawad, MD · March 20, 2026
- 483 · Alexander Glaros, M.D. · July 17, 2026
Frequently inspected with (10)
Chelsea W. Lamm
investigator
5 shared
Stephen O. Agyemang
3 shared
Victoria R. Flournoy
3 shared
Gene R. Gunn
investigator
2 shared
Jason Woodward
2 shared
Corrine M. Carter
investigator
1 shared
Daniel B Bordt
1 shared
Denise L. Burosh
Bioresearch Monitoring Specialis
1 shared
Jennifer A. Kemp
issuing_officer
1 shared
Mildred J. Tures
1 shared
Person Information
Name
Dina A. Tallman
Title
investigator
Role
COMPANY REP
ID: e9bf2b98-6697-4d7c-9052-84339536acfd
Get More Insights
Access our comprehensive quality intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
1.5M+ regulatory data points
Real-time compliance monitoring
Interactive analytics dashboard
Looking for more people? Our platform provides access to thousands of FDA people with advanced search and filtering capabilities.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.